James Bradner,Kimberly Stegmaier,Jun Qi,Anthony Varca,Giovanni Roti
申请号：
US15523518
公开号：
US20180280522A1
申请日:
2015.11.05
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to novel derivatives of thapsigargin that are chemically modified with a group that targets a cell surface-expressed receptor, and pharmaceutical preparations thereof. The invention further relates to methods of treating diseases such as cancer using the compounds of the invention.
